According to a recent study, pediatric patients with hidradenitis suppurativa (HS) have an increased prevalence of chronic medical and psychiatric comorbidities when compared to patients without HS.
HS patients at increased risk of anxiety disorders
According to a recent study, patients with hidradenitis suppurativa (HS) are at an increased risk of anxiety disorders such as phobic disorders, panic disorder, generalized anxiety disorder or unspecified anxiety.
EADV 2023 Day 4 Afternoon: JAK Inhibitors and Inflammatory Skin Disease
Dr. Ronald B. Vender reports live from the 2023 EADV Congress in Berlin and gives insights into JAK inhibitors and patient aspects of inflammatory skin diseases.
EADV 2023 Day 4 Morning: Congress Presentations of Interest
Dr. Ronald B. Vender reports live from the 2023 EADV Congress in Berlin and discusses the most popular topics of interest during the 32nd EADV Conference.
EADV 2023 Day 3 Evening: Abrocitinib for Prurigo Nodularis in Chronic Pruritus
Dr. Fiona Lovegrove reports live from the 2023 EADV Congress in Berlin and discusses the late breaking presentation on the efficacy and safety of abrocitinib for prurigo nodularis in chronic pruritus.
EADV 2023 Day 3 Afternoon: Efficacy and Safety of Rezpegaldesleukin
Dr. Fiona Lovegrove reports live from the 2023 EADV Congress in Berlin and discusses the late breaking presentation on rezpegaldesleukin.
EADV 2023 Day 3 Morning: Bullous Diseases
Dr. Fiona Lovegrove reports live from the 2023 EADV Congress in Berlin and gives insights into bullous diseases.
EADV 2023 Day 3 Evening: Molecular Signature of Chronic Hand Eczema
Dr. Vimal Prajapati reports live from the 2023 EADV Congress in Berlin and discusses the common molecular signature of chronic hand eczema.
EADV 2023 Day 2 Afternoon: Treating Severe Atopic Dermatitis with Tapinarof 1% Cream
Dr. Vimal Prajapati reports live from the 2023 EADV Congress in Berlin and discusses tapinarof 1% cream for treating severe atopic dermatitis
EADV 2023 Day 2 Morning: Late Breaking Psoriasis Presentations
Dr. Vimal Prajapati reports live from the 2023 EADV Congress in Berlin and discusses late breaker presentations around orally administered treatments for psoriasis
HealthMinute.TV 